T I Torkhovskaya - JoVE Visualize

Showing results (1-10 of 25) with videos related to

Pageof 3

Sort By:

Bulletin of Experimental Biology and Medicine|May 7, 2008

Lipidomics: new approaches to the studies of cell signaling and prospects of use in medicineT I Torkhovskaya, E M Khalilov, A A Korotaeva

Biochemistry. Biokhimiia|February 23, 2020

The Role of Halogenative Stress in Atherogenic Modification of Low-Density LipoproteinsO M Panasenko, T I Torkhovskaya, I V Gorudko, et al.

Biomedical Science|January 1, 1991

Diet-induced hypercholesterolaemia in the rabbitA S Ivanov, T I Torkhovskaya, E M Khalilov, et al.

Biochemistry. Biokhimiia|August 15, 2006

Sphingolipids and cell signaling: involvement in apoptosis and atherogenesisO M Ipatova, T I Torkhovskaya, T S Zakharova, et al.

Biochemistry. Biokhimiia|March 21, 2007

Lysophospholipid receptors in cell signalingT I Torkhovskaya, O M Ipatova, T S Zakharova, et al.

Bulletin of Experimental Biology and Medicine|September 8, 2000

Comparison of distribution characteristics of phosphatidylcholines and surfactant preparationT S Zakharova, E S Fortinskaya, M M Kochetova, et al.

Biomeditsinskaia Khimiia|February 21, 2018

[Pharmacological targets for dislipidemies correction. Opportunities and prospects of therapeutic usage]V A Kudinov, T S Zakharova, T I Torkhovskaya, et al.

Biomeditsinskaia Khimiia|April 16, 2021

[Plasma high density lipoproteins phospholipds as an indirect indicator of their cholesterol efflux capacity - new suspected atherosclerosis risk factor]Yu A Tereshkina, L V Kostryukova, T I Torkhovskaya, et al.

Biomeditsinskaia Khimiia|December 29, 2021

[The effect of lipid derivative of anti-tumor drug sarcolysin embedded in phospholipid nanoparticles in the experiments in vivo]Yu A Tereshkina, T I Torkhovskaya, M A Sanzhakov, et al.

Cor Et Vasa|January 1, 1981

The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteriesV S Gasilin, Kh A Kurdanov, N V Perova, et al.

Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:

Pageof 3

Bulletin of Experimental Biology and Medicine|May 7, 2008

Lipidomics: new approaches to the studies of cell signaling and prospects of use in medicineT I Torkhovskaya, E M Khalilov, A A Korotaeva

Biochemistry. Biokhimiia|February 23, 2020

The Role of Halogenative Stress in Atherogenic Modification of Low-Density LipoproteinsO M Panasenko, T I Torkhovskaya, I V Gorudko, et al.

Biomedical Science|January 1, 1991

Diet-induced hypercholesterolaemia in the rabbitA S Ivanov, T I Torkhovskaya, E M Khalilov, et al.

Biochemistry. Biokhimiia|August 15, 2006

Sphingolipids and cell signaling: involvement in apoptosis and atherogenesisO M Ipatova, T I Torkhovskaya, T S Zakharova, et al.

Biochemistry. Biokhimiia|March 21, 2007

Lysophospholipid receptors in cell signalingT I Torkhovskaya, O M Ipatova, T S Zakharova, et al.

Bulletin of Experimental Biology and Medicine|September 8, 2000

Comparison of distribution characteristics of phosphatidylcholines and surfactant preparationT S Zakharova, E S Fortinskaya, M M Kochetova, et al.

Biomeditsinskaia Khimiia|February 21, 2018

[Pharmacological targets for dislipidemies correction. Opportunities and prospects of therapeutic usage]V A Kudinov, T S Zakharova, T I Torkhovskaya, et al.

Biomeditsinskaia Khimiia|April 16, 2021

[Plasma high density lipoproteins phospholipds as an indirect indicator of their cholesterol efflux capacity - new suspected atherosclerosis risk factor]Yu A Tereshkina, L V Kostryukova, T I Torkhovskaya, et al.

Biomeditsinskaia Khimiia|December 29, 2021

[The effect of lipid derivative of anti-tumor drug sarcolysin embedded in phospholipid nanoparticles in the experiments in vivo]Yu A Tereshkina, T I Torkhovskaya, M A Sanzhakov, et al.

Cor Et Vasa|January 1, 1981

The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteriesV S Gasilin, Kh A Kurdanov, N V Perova, et al.

Pageof 3